Behaviour Change to Promote Diabetes Outcomes: Getting More From What We Have Through Dissemination and Scalability

Michael Vallis

doi:10.1016/j.jcjd.2022.08.008

Behaviour Change to Promote Diabetes Outcomes: Getting More From What We Have Through Dissemination and Scalability

Michael Vallis

Medicine

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

The potential benefits of advanced medical treatments (pharmacotherapies) and technologies (diagnostics, devices and apps) are unrealized due to lack of sustained behaviour change in individuals living with type 2 diabetes. The lack of scale-up of effective health behaviour change interventions limits health improvement. Identification of mediators of behaviour change (adherence, self-efficacy, intrinsic motivation) can address this limitation by shifting the focus of behaviour change from input (which behaviour change strategy to choose) to output (what can the person adhere to and sustain). Technology and accessing the workplace environment to promote change offer scalable opportunities for facilitating health behaviour change in populations.

Original language	English
Journal	Canadian Journal of Diabetes
DOIs	https://doi.org/10.1016/j.jcjd.2022.08.008
Publication status	Accepted/In press - 2022

Bibliographical note

Funding Information:
The author thanks Susanne Cookson for comments on earlier drafts of this article and for sharing her experiences running BestLifeRewarded Innovations.

Publisher Copyright:
© 2022 Canadian Diabetes Association

ASJC Scopus Subject Areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Endocrinology

PubMed: MeSH publication types

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jcjd.2022.08.008

Cite this

@article{a6384909e70146b89dfbef3926e4b3b9,

title = "Behaviour Change to Promote Diabetes Outcomes: Getting More From What We Have Through Dissemination and Scalability",

abstract = "The potential benefits of advanced medical treatments (pharmacotherapies) and technologies (diagnostics, devices and apps) are unrealized due to lack of sustained behaviour change in individuals living with type 2 diabetes. The lack of scale-up of effective health behaviour change interventions limits health improvement. Identification of mediators of behaviour change (adherence, self-efficacy, intrinsic motivation) can address this limitation by shifting the focus of behaviour change from input (which behaviour change strategy to choose) to output (what can the person adhere to and sustain). Technology and accessing the workplace environment to promote change offer scalable opportunities for facilitating health behaviour change in populations.",

author = "Michael Vallis",

note = "Funding Information: The author thanks Susanne Cookson for comments on earlier drafts of this article and for sharing her experiences running BestLifeRewarded Innovations. Publisher Copyright: {\textcopyright} 2022 Canadian Diabetes Association",

year = "2022",

doi = "10.1016/j.jcjd.2022.08.008",

language = "English",

journal = "Canadian Journal of Diabetes",

issn = "1499-2671",

publisher = "Canadian Diabetes Association",

}

TY - JOUR

T1 - Behaviour Change to Promote Diabetes Outcomes

T2 - Getting More From What We Have Through Dissemination and Scalability

AU - Vallis, Michael

N1 - Funding Information: The author thanks Susanne Cookson for comments on earlier drafts of this article and for sharing her experiences running BestLifeRewarded Innovations. Publisher Copyright: © 2022 Canadian Diabetes Association

PY - 2022

Y1 - 2022

N2 - The potential benefits of advanced medical treatments (pharmacotherapies) and technologies (diagnostics, devices and apps) are unrealized due to lack of sustained behaviour change in individuals living with type 2 diabetes. The lack of scale-up of effective health behaviour change interventions limits health improvement. Identification of mediators of behaviour change (adherence, self-efficacy, intrinsic motivation) can address this limitation by shifting the focus of behaviour change from input (which behaviour change strategy to choose) to output (what can the person adhere to and sustain). Technology and accessing the workplace environment to promote change offer scalable opportunities for facilitating health behaviour change in populations.

AB - The potential benefits of advanced medical treatments (pharmacotherapies) and technologies (diagnostics, devices and apps) are unrealized due to lack of sustained behaviour change in individuals living with type 2 diabetes. The lack of scale-up of effective health behaviour change interventions limits health improvement. Identification of mediators of behaviour change (adherence, self-efficacy, intrinsic motivation) can address this limitation by shifting the focus of behaviour change from input (which behaviour change strategy to choose) to output (what can the person adhere to and sustain). Technology and accessing the workplace environment to promote change offer scalable opportunities for facilitating health behaviour change in populations.

UR - http://www.scopus.com/inward/record.url?scp=85139339426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85139339426&partnerID=8YFLogxK

U2 - 10.1016/j.jcjd.2022.08.008

DO - 10.1016/j.jcjd.2022.08.008

M3 - Article

C2 - 36184369

AN - SCOPUS:85139339426

SN - 1499-2671

JO - Canadian Journal of Diabetes

JF - Canadian Journal of Diabetes

ER -

Behaviour Change to Promote Diabetes Outcomes: Getting More From What We Have Through Dissemination and Scalability

Abstract

Bibliographical note

ASJC Scopus Subject Areas

PubMed: MeSH publication types

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this